Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Harbin Pharmaceutical Group Sanjing Mingshui Pharmaceutical is a specialized pharmaceutical subsidiary of the Harbin Pharmaceutical Group (Hayao), a leading player in the Chinese healthcare industry. Located in Mingshui County, Heilongjiang Province, the company serves as a critical manufacturing hub for the group's Sanjing brand, which is widely recognized for its over-the-counter (OTC) products. Its primary business involves the production and distribution of traditional Chinese medicines (TCM), chemical drug preparations, and nutritional supplements. The facility is particularly noted for its high-volume production of oral liquid products, including calcium and zinc gluconate solutions. Operating under strict Good Manufacturing Practice (GMP) standards, the company ensures the quality and safety of its diverse product portfolio while supporting Hayao's extensive domestic supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Harbin Pharmaceutical Group Sanjing Mingshui Pharmaceutical.